Supported projects

Ongoing projects

AXIS 1: CLINICAL AND TREATMENT RESEARCH

National Parkinson Foundation Patient Registry – Lafontaine, MD, MSC – McGill University / National Parkinson Foundation

Effect of long-acting levodopa on obstructive sleep apnea in Parkinson’s disease – Kaminska, MD, MSc – McGill University

Imaging brain structures involved in human walking with Parkinson’s disease (PD) – Paquette, PhD, Dr Soucy, MD – McGill University

Impact of an exercise program on proprioceptive performance in Parkinson’s disease – Messier, PhD, Blanchet, Md, PhD – University of Montreal

A novel exercise modality to improve motor learning in PD - Roig, PhD – McGill University

Home and community mobility in elderly healthy individuals ans patients with Parkinson’s disease

The impact of drug-induced dyskinesia and its management on daily-life activities

AXIS 2: NON-MOTOR SYMPTOMS

MRI and Virtual Navigational Strategies in Parkinson’s Disease – Bohbot, PhD – McGill University, University of Montreal

Role of brain cholinergic degenerations in the Mild Cognitive Impairment of Parkinson’s disease: A PET study with the 18F-Fluoroethoxybenzovesamicol (FEOBV) – Bédard, PhD – UQAM, UdeM, McGill University

The effects of eye-movement training on cognitive performance – Khan, PhD – University of Montréal

Percpetual-Cognitive Training in PD - Faubert, PhD – University of Montreal

Electrical Brain Stitmulation and Impulsive Control Disorders

AXIS 3: MOLECULAR AND CELLULAR BIOLOGY

Montreal Neurological Institute Biobank (MNI-BB)

Targeted Next-Generation Sequencing and Genome-Wide Association Study of Parkinson’s disease patients in Quebec

Epidemiological and genetic study of Parkinson’s disease in Quebec

Clinical – genetic study of GBA mutations in Parkinson’s disease and REM sleep Behavior Disorder

———————————————————————————————–

Completed Project

AXIS 1: CLINICAL AND TREATMENT RESEARCH

Assessment of gait sensors for Parkinson’s disease – Mc Laren, PhD – Concordia University

Comparison of the efficiency of levodopa and dopamine agonists on the mobility in the community and the physical activity level of people with Parkinson’s disease

Treatment of sleep apnea in Parkinson’s disease

Detection and automatic follow-up of the motor symptoms in patients with Parkinson’s disease

Caffeine as a Therapeutic Agent in Parkinson’s disease

Association of Cognitive dysfunction with Orthostatic Hypotension in patients with Parkinson’s disease

Validation of the Movement Disorders Society PD diagnostic criteria

The effect of cardiorespiratory exercice on motor skill learning in Parkinson’s disease

Freezing mechanisms in Parkinson’s disease

AXIS 2: NON-MOTOR SYMPTOMS

Smoking and Cognition in Parkinson’s disease

Cognitive effect of transcranial magnetic stimulation on patients with Parkinson’s disease and mild cognitive impairment

Cognitive Reserve and Parkinson Disease : Can an extra Language help in more ways than one ?

Studying the resting-state networks associated with cognitive deficits in Parkinson’s disease (PD)

AXIS 3: MOLECULAR AND CELLULAR BIOLOGY

Genome wide association study of Parkinson’s disease and REM sleep Behavior Disorder

Targeted next generation sequencing of 58 Parkinson’s disease- related genes

The role of SMPD1 in Parkinson’s disease

Association study of the melanoma gene MC1R and Parkinson’s disease

The interplay between nicotinic receptor and nicotine metabolism genes, smoking and Parkinson’s disease

DNAJC13 in Parkinson’s disease

Study of novel familial genes in Parkinson’s disease

Replication study of essential tremor genetic loci in Parkinson’s disease

Study of HIP1R, LRRK2 and SNCA in Parkinson’s disease